Category

Blastoma

Study suggests new approach to improve radiation therapy resistance in glioblastoma Blastoma

Study suggests new approach to improve radiation therapy resistance in glioblastoma

Many modern cancer drugs target a specific genetic mutation that is driving a particular cancer's runaway growth and division -- such as the HER-2 protein in some breast cancers or EGFR in certain lung cancers. But this strategy hasn't worked well against glioblastoma, an aggressive form of brain cancer, which…
bubmag
July 30, 2020
Leukemia drug shows the potential to treat aggressive pediatric brain câncer Blastoma

Leukemia drug shows the potential to treat aggressive pediatric brain câncer

IMAGE: A) Arsenic Trioxide (ATO) reduces the clonogenic capacity of medulloblastoma (MB) cell lines of the SHH subgroup (DAOY: TP53 c.725G>T; UW402: TP53 c.464C>A and ONS-76: TP53 wild type). B) Clonogenic... view more  Credit: Paulo Henrique dos Santos Klinger By André Julião | Agência FAPESP – Researchers affiliated with the University…
bubmag
July 21, 2020
Tumour predisposition and cancer syndromes as models to study gene–environment interactions Blastoma

Tumour predisposition and cancer syndromes as models to study gene–environment interactions

AbstractCell division and organismal development are exquisitely orchestrated and regulated processes. The dysregulation of the molecular mechanisms underlying these processes may cause cancer, a consequence of cell-intrinsic and/or cell-extrinsic events. Cellular DNA can be damaged by spontaneous hydrolysis, reactive oxygen species, aberrant cellular metabolism or other perturbations that cause DNA…
bubmag
May 29, 2020
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor Blastoma

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

Loading metrics Open Access Peer-reviewed Research Article Melissa F. Adasme , Daniele Parisi , Kristien Van Belle, Sebastian Salentin, V. Joachim Haupt, Gary S. Jennings, Jörg-Christian Heinrich, Jean Herman, Ben Sprangers, Thierry Louat, Yves Moreau, Michael Schroeder Melissa F. Adasme,  Daniele Parisi,  Kristien Van Belle,  Sebastian Salentin,  V. Joachim Haupt, …
bubmag
May 27, 2020
Low dose of luteolin activates Nrf2 in the liver of mice at start of the active phase but not that of the inactive phase Blastoma

Low dose of luteolin activates Nrf2 in the liver of mice at start of the active phase but not that of the inactive phase

Loading metrics Open Access Peer-reviewed Research Article Tomoya Kitakaze,  Atsushi Makiyama,  Yoko Yamashita,  Hitoshi Ashida x Published: April 9, 2020 https://doi.org/10.1371/journal.pone.0231403 AbstractA flavone luteolin has various health-promoting activities. Several studies reported that high dose of luteolin activates the Nrf2/ARE pathway in the liver. However, the effect of the low dose…
bubmag
April 9, 2020
‘Never give up hope’: Pennsylvania twin toddlers have been battling cancer since birth Blastoma

‘Never give up hope’: Pennsylvania twin toddlers have been battling cancer since birth

YORK, Pa. – Eve and Ella Oakley’s wish has come  true. The twins are on vacation in Florida.They’re taking a break from the hospitals and tests and therapies in their battle with cancer, a war they’ve waged since they were born two years ago.And it isn’t the only battle they’ve endured.“Literally, the…
bubmag
March 8, 2020
‘Never give up hope’: Pennsylvania twin toddlers have been battling cancer since birth Blastoma

‘Never give up hope’: Pennsylvania twin toddlers have been battling cancer since birth

Kim Strong York Daily RecordPublished 2:28 PM EDT Mar 8, 2020YORK, Pa. – Eve and Ella Oakley’s wish has come  true. The twins are on vacation in Florida.They’re taking a break from the hospitals and tests and therapies in their battle with cancer, a war they’ve waged since they were born two…
bubmag
March 8, 2020